⌘K

Home/Filings/4/0001618835-19-000214

4//SEC Filing

Culwell Kelly 4

Accession 0001618835-19-000214

CIK 0001618835other

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:34 PM ET

Size

4.8 KB

Accession

0001618835-19-000214

Insider Transaction Report

Form 4

Period: 2019-12-02

Evofem Biosciences, Inc.EVFM

Chief Medical Officer

Transactions

Sale
Common Stock
2019-12-02$7.35/sh−1,000$7,350→ 43,538 total

Footnotes (1)

[F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.

Documents

1 file

4
wf-form4_157549882846938.xmlPrimary
FORM 4

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1

filerCIK 0001726183

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 5:34 PM ET
Size: 4.8 KB

View on SEC.gov